Title: |
Guidelines for the diagnosis and treatment of high-risk human papillomavirus infection using a combination of traditional Chinese and Western medicine |
Edition: |
Original |
Classification: |
Traditional Chinese Medicine guideline |
Field: |
Comprehensive guideline |
Countries and regions: |
China |
Guidelines users: |
Traditional Chinese Medicine Practitioner, Integrated Traditional Chinese and Western Medicine Practitioner, Western Medicine Practitioner |
Evidence classification method: |
GRADE Evidence Grading Method |
Development unit: |
Guangdong Provincial Hospital of Traditional Chinese Medicine (Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine) |
Registration time: |
2024-02-09 |
Registration number: |
PREPARE-2024CN263 |
Purpose of the guideline: |
The incidence rate of cervical cancer is the second highest among female malignant tumors in the world. High risk human papilloma virus (HR-HPV) infection is the main cause of cervical cancer. Preventing HR-HPV infection and timely and effective intervention of already infected HR-HPV can make cervical cancer a preventable and treatable disease.
So far, there is no internationally recognized drug that can effectively clear HR-HPV, and various treatment options are still being actively explored. Clinical efficacy cannot be guaranteed. Therefore, based on evidence-based treatment, fully exploring the treatment methods of traditional Chinese and Western medicine, and forming the "Guidelines for the Combined Diagnosis and Treatment of High Risk Human Papillomavirus Infection" is of great significance for the standardized clinical treatment of HR-HPV infection.
This guideline is based on evidence-based treatment for patients with persistent HR-HPV infection, SPI, low-grade cervical lesions, and high-grade cervical lesions who have not turned negative after treatment. Treatment standards are developed to meet clinical needs and provide the best diagnostic and treatment services for patients. The combination of traditional Chinese and Western medicine can refer to this guideline for the treatment of HR-HPV infections in the cervix, vulva, and vagina. |